Novel Cyclic Lipodepsipeptide from Pseudomonas syringae pv. lachrymans Strain 508 and Syringopeptin Antimicrobial Activities

Author:

Grgurina Ingeborg1,Bensaci Mekki2,Pocsfalvi Gabriella3,Mannina Luisa45,Cruciani Oscar5,Fiore Alberto6,Fogliano Vincenzo6,Sorensen Kevin N.7,Takemoto Jon Y.2

Affiliation:

1. Dipartimento di Scienze Biochimiche “A. Rossi Fanelli,” Università “La Sapienza” di Roma, P.le A. Moro 5, 00185 Roma, Italy

2. Department of Biology, Utah State University, Logan, Utah 84322-5305

3. Centro Internazionale di Servizi di Spettrometria di Massa, Istituto di Scienze dell'Alimentazione del CNR, Via Roma 52, I-83100 Avellino, Italy

4. Dipartimento di Scienze e Tecnologie Agroalimentari, Ambientali e Microbiologiche, Università del Molise, 86100 Campobasso, Italy

5. Institute of Chemical Methodologies, National Research Council, 00016 Monterotondo Stazione, Rome, Italy

6. Dipartimento di Scienza degli Alimenti, Università di Napoli “Federico II,” Parco Gussone, Edificio 84, 80055 Portici, Naples, Italy

7. Department of Life Sciences, Snow College, Ephraim, Utah 84627

Abstract

ABSTRACT The syringopeptins are a group of antimicrobial cyclic lipodepsipeptides produced by several plant-associated pseudomonads. A novel syringopeptin, SP508, was shown to be produced as two homologs (A and B) by Pseudomonas syringae pv. lachrymans strain 508 from apple and to structurally resemble syringopeptin SP22. SP508 differed from SP22 and other syringopeptins by having three instead of four α,β-unsaturated amino acids and a longer β-hydroxy acyl chain. Both SP508 and SP22 displayed growth-inhibitory activities against Mycobacterium smegmatis , other gram-positive bacteria, and yeasts but not against gram-negative bacteria. Structure-activity analyses of the SP508 and SP22 homologs indicated chemical structural features that lead to enhanced antimycobacterial activity by these pseudomonad cyclic lipodepsipeptides.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3